Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 26, 652-658, April 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cantarow, A.
Right arrow Articles by Goddard, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cantarow, A.
Right arrow Articles by Goddard, J. W.

Tumors in the Rat after Injection of Neoplastic and Preneoplastic Nucleic Acids1

A. Cantarow, T. L. Williams and J. W. Goddard

Departments of Biochemistry and Medicine, Jefferson Medical College, Philadelphia, Pennsylvania

Hepatomas occurred in the liver of 5 of 386 ACI rats at the site of injection, 10–16 weeks previously, of cells of regenerating liver pre-incubated with DNA derived from the Morris hepatoma 3924C, transplantable in this strain. A tumor of undetermined nature developed in 1 of 62 rats 6 months after in trahepatic injection of a mixture of preneoplastic liver DNA and RNA.

No tumors occurred in 1480 other ACI rats (No. in parentheses) treated as follows: I. intrahepatic injection of regenerating liver cells pre-incubated with (a) hepatoma RNA (340), (b) preneoplastic DNA (124), (c) normal liver DNA (40), and (d) normal liver RNA (40); II. intrahepatic injection of (a) hepatoma DNA (280), (b) hepatoma RNA (246), (c) preneoplastic liver DNA (166), (d) preneoplastic liver RNA (184), (e) normal liver DNA (30), and (f) normal liver RNA (30).

The circumstances under which the hepatomas occurred seem to warrant the conclusion that a process of cell transformation by the hepatoma DNA was involved in their pathogenesis.

1 Supported in part by USPHS Grant Ca-07212 from the National Cancer Institute.

Received 6/ 7/65. Revised 9/ 9/65.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1966 by the American Association for Cancer Research.